USD 25.2 billion
Report ID:
SQMIG35G2281 |
Region:
Global |
Published Date: June, 2024
Pages:
157
|Tables:
94
|Figures:
76
Global Proteomics Market size was valued at USD 25.2 billion in 2022 and is poised to grow from USD 29.35 billion in 2023 to USD 100.17 billion by 2031, growing at a CAGR of 16.55% in the forecast period (2024-2031).
According to Globocan, there will be 19.3 million new cases of cancer worldwide with 10 million cancer-related deaths reported. CVDs are one of the leading causes of death worldwide. According to the WHO, target diseases kill 41 million people each year. Thus, as the prevalence of life-threatening diseases rises, so does the demand for personalised therapies, resulting in a positive impact on the industry. Another factor expected to drive market growth is the rising prevalence of chronic diseases such as cancer, cardiovascular diseases (CVDs), respiratory diseases, CKD, and others.
Increased investments in proteomics R&D are a growth driver in the field of proteomics. The National Institutes of Health (NIH) of the United States provided $37 billion for biomedical research. This funding was intended to support life sciences research that sought to understand the fundamental processes by which diseases develop, such as the identification of biomarkers that indicate the presence of disease or the identification of the gene/protein responsible for the disease. The Novo Nordisk Foundation awarded the University of Copenhagen a grant of up to $1.5 million to establish a mass spectrometry facility, which is a significant step forward in protein research. The Global Proteomics Market is also expected to pick up steam following the consistent resumption of the activities in the midst of the pandemic which has caused a worldwide disruption in operating activities.
US Proteomics Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 25.2 billion
Largest Segment
Reagents & Consumables
Fastest Growth
Services
Growth Rate
16.55% CAGR
To get more reports on the above market click here to Buy The Report
The global proteomics market is segmented based on the Instrumentation Technology, Reagent, Software &Services, Application, End User and Region. Based on the Instrumentation Technology, the market is segmented into Services, Reagents & Consumables, and Instruments. Based on Reagent, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents, Other Reagents. Based on Software & Services, the market is segmented into Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomics Services, Protein Purification Services, Protein Separation Services, Protein Sequencing Services, Custom Assay Services), Bioinformatics Software & Services (Bioinformatics Services, Bioinformatics Tools, Bioinformatics Databases), Photonic Network, Other Technologies. Based on Application, the market is segmented into Clinical Diagnostics (Cancer, Infectious Diseases, Diabetes, Neurological Disorders, Autoimmune Diseases, Cardiovascular Diseases, Other Clinical Diagnostic Applications), Drug Discovery & Development (Target Discovery, Lead Identification, Preclinical Studies), and Other Applications. Based on End User, the market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Laboratories, and Other End Users. Based on Region, the market is segmneted into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
Analysis by Reagent
In 2023, the spectroscopy segment is expected to dominate the market and will continue growing rapidly during the forecast period. The main reasons for such growth include the high versatility of spectroscopy technologies in multiple sectors of analysis, including biochemistry creation, proteomics, metabolomics, forensic sciences, and pharmaceutical fields. These technologies are quite useful in these fields due to their flexibility and effectiveness, and hence their increasing acceptance and domination in these fields.
The growing number of microarray applications across various fields is also expected to contribute towards the growth of microarray industries in the near future. Microarray analysis has been found to be most useful in antibiotic therapy because the bacterial genomic DNA withstands degradation and may remain longer than the bacteria. DNA-based microarray scanning has emerged as the most popular method for gene expression analysis since the technology is simple and relatively cheaper, which improves the technology complexity and applicability. Other studies like this make it evident that microarrays are now crucial tools in contemporary analytical approaches.
Analysis by Application
According to the statistic, in the year 2023, the clinical diagnostics industry remained on the apex and took a good share of 51%. It reveals 65% market share in the industry as its major highlight. This can be attributed to the fact that protein analysis has found wide acceptance by clinical researchers who are in search of disease biomarkers to facilitate early diagnosis as well as to establish individual susceptibility factors. Such advancements provide the platform for new forms of prevention and early stage disease control. The diagnostics based on proteomics allow one to find biomarkers, as well as protein expression profiles, which are extremely useful for the tumor classification, prognosis, and the subsequent growth of this segment.
On the other hand, the drug discovery & development segment is expected to grow at the fastest pace in the forecast span. This may be due to improvements in utilizing structure-based drug design, the emphasis of creating bespoke drugs, as well as increased funding towards these fields. Additionally, proteomics technologies offer initial specifications in medicine development platforms, thereby saving large amounts of cash for pharmaceutical firms and thereby assisting patients and healthcare systems, therefore contributing further to the segment’s expansion.
To get detailed analysis on other segments, Request For Free Sample Report
North America dominated the market in 2023 and accounts for 45% of total revenue. This is due to increased investments in structure-based drug design, growth in omics research, demand for high-quality research tools for data reproducibility and focus on the development of tailored treatments. Partnerships and collaborations among major companies in this region are also assisting in the market's expansion. Thermo Fisher Scientific Inc. and Symphogen, for example, collaborated to develop validated platform processes for the streamlined characterization and quality monitoring of complex therapeutic proteins.
The Asia-Pacific region is expected to grow at the fastest CAGR between 2022 and 2031, owing to an increase in proteomics-based project outsourcing, public and private funding for proteomics research and development, favourable government regulations, rising prevalence of target diseases with an ageing population, and rising proteomics adoption. For example, the University of Hyderabad received $60 million in funding from the Indian government's Department of Biotechnology to study the tomato proteome. Such government measures to support proteomics research are driving the market in Asia-Pacific.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Proteomics Market Driver
Technological Advancements Driving the Market
The drivers that fuel the proteomics market include increased growth in technologies such as mass spectrometry coupled and complex chromatography, which boost the precision and speed of protein analysis. These innovations help in the identification and quantification of proteins and hence lead to the use of proteomics in fields like drug discovery and diagnostics and even in the clinic.
Increasing R&D Investments
One of the key factors for the proteomics is rising investment in research and development undertook by the companies in the field of pharmaceutical and biotechnology. Increased funding or financing aids in the development or expansion of the proteomics market through research and discovery of proteomic uses such as biomarkers and therapeutic targets.
Proteomics Market Restrains
High Costs technologies and equipment
Another factor that attribute to the proteomic market restraint is the possibility of high cost of buying proteomic technologies and equipment. The cost of purchasing such equipment as the mass spectrometers and its maintenance remain high, thus not easily affordable by every researcher or research institute, thereby making the usage of such instruments restricted.
Complex Data Analysis
This is a challenge arising from the fact that the actual act of examining proteomic data often comes with much complexity. Bioinformatics can be time-consuming, labor-intensive, and may need extensive tooling and time and expertise to operate these tools, which may be hard to acquire. This can retard the research process and subsequently nullify the possible advantages proteomics have for clinical as well as research applications.
Request Free Customization of this report to help us to meet your business objectives.
The players are adopting various strategies for enhancing market penetration, some of which most significant are mergers & acquisitions, geographical expansions, and strategic partnerships. For instance, Seer, Inc. made the Broad Commercial Release of The Proteograph Product Suite and the new program called the Centers of Excellence in January of the year 2022. In detail, the Proteograph Product Suite offers comprehensive, impartial exposure to the entire proteome. The method relies on specially fabricated nanoparticles to produce a disruptive product that facilitates the large-scale and high-throughput and non-biased proteomics studies.
Proteomics Market Top Company Profiles
Proteomics Market Recent Developments
In February 2023, Waters Corporation acquired Wyatt Technology, which enhances the portfolio of Separation and Detection, which provides customers with an unmatched set of analytical solutions across a wide range of applications.
In June 2024, Biognosys, a prominent biotechnology company headquartered in Schlieren, Switzerland, has introduced its ground breaking P2 Plasma Enrichment method. This groundbreaking strategy employs a single particle-type enrichment approach that could potentially transform plasma proteomics using mass spectrometry.
In February 2024, SPOC Proteomics, Inc., a Scottsdale, Arizona-headquartered deep-tech life sciences company that also has operations in Menlo Park, California, introduced its sensor-integrated proteome on chip (SPOC®) biosensors.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our proteomics market analysis, it has been identified that the increasing incidences of cancer as well as other diseases are acting as the main driving forces for the growth of the Global Proteomics Industry. Proteomics is currently a field of continued study and exploration, and it can aid doctors in their knowledge of how proteins behave in a very dynamic context such as within a cancer patient. This stems from the fact that the field of proteomics is capable of acquiring pertinent information in the form of biomarkers. However, there are some constraint which restricts the growth of the Global Proteomics Market. One cannot venture into proteomics unless one is willing to invest a good deal of money on the equipment used to perform the processes which are experimented due to the research work done mainly through trial and error.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 25.2 billion |
Market size value in 2031 | USD 100.17 billion |
Growth Rate | 16.55% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Proteomics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Proteomics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Proteomics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Proteomics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35G2281